MedTrace Logo

Eosinophilic Esophagitis: Influence of Dilation on Dysphagia and Inflammation

NCT00667524 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 207

Last updated 2009-12-29

No results posted yet for this study

Summary

A database analysis and review of histological slides (retrospective) and a patient questionnaire analysis (prospective) will be conducted in Bern (Switzerland) to evaluate the efficacy and safety of esophageal dilation and its effect on the underlying eosinophilic inflammation in patients with Eosinophilic Esophagitis. This trial is investigator driven.

Conditions

  • Eosinophilic Esophagitis
  • Esophageal Stenosis
  • Esophageal Dilation
  • Esophageal Dilatation

Sponsors & Collaborators

  • Northwestern University Feinberg School of Medicine

    collaborator OTHER

  • University of Bern

    lead OTHER

Principal Investigators

  • Alain Schoepfer, Dr · Dpt of Gastroenterology, Bern University Hospital, Bern

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-02-29
Primary Completion
2009-03-31
Completion
2009-03-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00667524 on ClinicalTrials.gov